Biology subjects

Vemuri, P.

Publications and source records attributed to Vemuri, P..

5 recordsLinked to original sources

bioRxiv2026

Comparing Harmonization Approaches for Protocol-Related Variability in Multisite Diffusion MRI Data

Diffusion MRI (dMRI) enables assessment of white matter microstructural abnormalities in Alzheimers disease (AD), and multisite datasets enable more robust modeling of non-biological variation that can confound analyses. The Alzheimers Disease Neuroimaging Initiative (ADNI) includes over 10 dMRI protocols, necessitating robust methods to model protocol-related variability when pooling data. Here, we compared three harmonization approaches: (1) mixed-effects models, (2) ComBat-GAM, and (3) eHarmonize, a reference-based lifespan method. We assessed their ability to reduce protocol-related variability in diffusion tensor imaging fractional anisotropy (FA) and mean diffusivity (MD) while preserving associations with cognitive impairment (CI), and amyloid-beta (A{beta}) and tau PET burden in 1,086 ADNI3/4 participants. All approaches yielded more closely aligned FA/MD distributions across protocols. Associations with clinical indicators of CI were highly consistent across approaches, whereas PET associations were less widespread and more variable. Overall, multiple strategies effectively modeled protocol-related variability while preserving AD-related associations.

neuroscience↗

bioRxiv2026

Multi-Contrast MRI Inputs Enable Self-Consistent Tissue Segmentation & Robust Perivascular Space Identification

Different MRI image contrasts are designed to highlight various tissue properties and combining them allows extension of probabilistic segmentation beyond the commonly used "gray-white-CSF" models. This work describes a fully automated method that combines T1-weighted, T2-FLAIR, and conventional T2-weighted images to provide internal consistency across prediction of tissue segmentations including segmentation of superficial and deep gray matter, white matter hyperintensities, and MR-visible perivascular spaces. Results from 773 imaging datasets from 403 participants in the Mayo Clinic Study of Aging and Mayo Clinic Alzheimers Disease Research Center (ADRC) are presented.

neuroscience↗

bioRxiv2026

Diffusion MRI based biomarkers reveal a Prolonged Pre Lesional Phase of Cerebral Small Vessel Disease

BackgroundWhite matter hyperintensities (WMH) are widely used to assess cerebral small vessel disease (SVD) but reflect late-stage injury. Diffusion MRI based biomarkers have been proposed to capture earlier SVD-related microstructural damage but their temporal progression relative to WMH and the risk factors associated with this progression have not been explored. MethodsWe analyzed longitudinal neuroimaging data from 2,047 participants from a population-based cohort study (aged 49-101 years, 47% female). Using multi-output nonlinear mixed-effects models, we characterized the temporal progression of WMH and four diffusion MRI based biomarkers: fractional anisotropy of the genu of the corpus callosum (Genu-FA), peak width of skeletonized mean diffusivity (PSMD), free water (FW), and Arteriolosclerosis-score (ARTS). Models incorporated participant-specific time shifts, correlations between biomarkers, and effects of risk factors (sex, education, APOE {varepsilon}4 status, and cardiometabolic conditions). ResultsARTS, Genu-FA, FW, and PSMD became abnormal in 50% of the study population 16, 12, 10, and 7 years before WMH, respectively. Global markers (ARTS, FW, PSMD, WMH) were correlated, indicating shared substrates of widespread white matter injury. Genu-FA, a vascular risk microstructural injury biomarker, was weakly coupled with WMH and had an earlier but more linear worsening across adulthood. Cardiometabolic conditions predicted earlier worsening of all biomarkers. Females showed earlier WMH, Genu-FA, and ARTS abnormalities whereas males exhibited earlier PSMD and FW abnormalities. ConclusionsDiffusion MRI based biomarkers capture microstructural injury at least a decade before appearance of WMH, revealing a prolonged phase of early SVD and highlighting their potential for SVD prevention.

neuroscience↗

bioRxiv2021

Single-cell transcriptomics for the 99.9% of species without reference genomes

Single-cell RNA-seq (scRNA-seq) is a powerful tool for cell type identification but is not readily applicable to organisms without well-annotated reference genomes. Of the approximately 10 million animal species predicted to exist on Earth, >99.9% do not have any submitted genome assembly. To enable scRNA-seq for the vast majority of animals on the planet, here we introduce the concept of "k-mer homology," combining biochemical synonyms in degenerate protein alphabets with uniform data subsampling via MinHash into a pipeline called Kmermaid. Implementing this pipeline enables direct detection of similar cell types across species from transcriptomic data without the need for a reference genome. Underpinning Kmermaid is the tool Orpheum, a memory-efficient method for extracting high-confidence protein-coding sequences from RNA-seq data. After validating Kmermaid using datasets from human and mouse lung, we applied Kmermaid to the Chinese horseshoe bat (Rhinolophus sinicus), where we propagated cellular compartment labels at high fidelity. Our pipeline provides a high-throughput tool that enables analyses of transcriptomic data across divergent species transcriptomes in a genome- and gene annotation-agnostic manner. Thus, the combination of Kmermaid and Orpheum identifies cell type-specific sequences that may be missing from genome annotations and empowers molecular cellular phenotyping for novel model organisms and species.

bioinformatics↗

bioRxiv2019

Fully Bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression

Tau pathology and regional brain atrophy are the closest correlate of cognitive decline in Alzheimers disease (AD). Understanding heterogeneity and longitudinal progression of brain atrophy during the disease course will play a key role in understanding AD pathogenesis. We propose a framework for longitudinal clustering that: 1) incorporates whole brain data, 2) leverages unequal visits per individual, 3) compares clusters with a control group, 4) allows to study confounding effects, 5) provides clusters visualization, 6) measures clustering uncertainty, all these simultaneously. We used amyloid-{beta} positive AD and negative healthy subjects, three longitudinal sMRI scans (cortical thickness and subcortical volume) over two years. We found 3 distinct longitudinal AD brain atrophy patterns: a typical diffuse pattern (n=34, 47.2%), and 2 atypical patterns: Minimal atrophy (n=23 31.9%) and Hippocampal sparing (n=9, 12.5%). We also identified outliers (n=3, 4.2%) and observations with uncertain classification (n=3, 4.2%). The clusters differed not only in regional distributions of atrophy at baseline, but also longitudinal atrophy progression, age at AD onset, and cognitive decline. A framework for the longitudinal assessment of variability in cohorts with several neuroimaging measures was successfully developed. We believe this framework may aid in disentangling distinct subtypes of AD from disease staging.

neuroscience↗